Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Breast Cancer Research : BCR|May 24, 2017
An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validationFrancisco J Candido Dos Reis, Gordon C Wishart, Ed M Dicks, et al.
Medrxiv : the Preprint Server for Health Sciences|April 18, 2024
Exome sequencing identifies HELB as a novel susceptibility gene for non-mucinous, non-high-grade-serous epithelial ovarian cancerEd M Dicks, Jonthan P Tyrer, Suzana Ezquina, et al.
Scientific Reports|February 8, 2014
Clinical characteristics of ovarian cancer classified by BRCA1, BRCA2, and RAD51C statusJ M Cunningham, M S Cicek, N B Larson, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Saturation Genome Editing reveals the functional impact of RAD51D and XRCC2 variantsSilvia Casadei, Matthew W Snyder, Ivan Woo, et al.
European Journal of Human Genetics : EJHG|February 12, 2025
Exome sequencing identifies HELB as a novel susceptibility gene for non-mucinous, non-high-grade-serous epithelial ovarian cancerEd M Dicks, Jonthan P Tyrer, Suzana Ezquina, et al.
Journal of Medical Genetics|June 18, 2020
Population-based targeted sequencing of 54 candidate genes identifies PALB2 as a susceptibility gene for high-grade serous ovarian cancerHonglin Song, Ed M Dicks, Jonathan Tyrer, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 10, 2016
Investigation of Exomic Variants Associated with Overall Survival in Ovarian CancerStacey J Winham, Ailith Pirie, Yian Ann Chen, et al.
Gynecologic Oncology|May 6, 2015
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer, Antoinette Hollestelle, Frederieke H van der Baan, et al.
Pageof 4